Please login to the form below
pricing model
This page shows the latest pricing model news and features for those working in and with pharma, biotech and healthcare.
US start-up EQRx promises approach that will slash drug prices
EQRx is co-founded by Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center whose academic interests focus on pricing as well as ... Bach recently proposed a model for selecting drugs for pricing
Latest news
-
Senate grilling makes pharma CEOs squirm, but give little ground
a cap on Medicare out of pocket payments, and supported value-based payments as a future pricing model. ... grilling. Despite being a longstanding critic of pharma’s pricing, Grassley has also indicated he wants to work with the sector on reform if
-
Amgen CEO says Aimovig is “one of most successful launches”
The Repatha discount comes as the US administration is ramping up the pressure on the biopharma industry on drug pricing, most recently proposing a reference pricing model to bring process closer
-
US pricing plan slammed for imposing “foreign price controls”
Gellad also says in a blog post on Stat News that the plans are long on rhetoric but short on concrete plans to implement the reference pricing system, providing “just a
-
Safety first: AI adoption in the healthcare sector
Cost: agree a clear pricing model, which could be licence- or transaction-based and may also have elements of risk and reward.
-
Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched
evidence route which would demonstrate the benefits of the treatment and allow an outcomes-based pricing model.
More from news
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest Intelligence
-
Assessing the risks in annuity pricing models
The challenge of adapting pricing models to accommodate new therapies. By Walter Colasante. ... pricing model.
-
Brexit and Trump
that we need to return to servicing a high-volume, low-cost model in consumer healthcare, and a parity pricing model in Rx.
-
Pharma deals in September 2015
to pursue a “robust” pricing model. ... Pharmaceuticals. He has also written a letter to employees to assuage their concerns over company's business model, potential exposure and the fall in the company's stock price (it fell
-
Interview: Richard Bergström, EFPIA
These are good examples of where legislation helps promote innovation, but unfortunately it's the access to markets, pricing and reimbursement that are deteriorating. ... I have worked very closely with the Swedish government to shape value-based-pricing.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Innovation in pharma: the highs and lows of the current healthcare economy
concerns. New entrants at both ends of the pricing spectrum. So while challenges remain, biosimilars seem to be finding their place in the market and creating a new and interesting dynamic, ... the system with a manageable pricing model to suit.
-
Ed Schoonveld - new article
Following the publication of the new edition of The Price of Global Health, Ed Schoonveld writes about the industry's need for new drug pricing model. ... Does the drug industry need a new pricing model? Read Ed Schoonveld's article here . The new
-
Emerging Markets: The Second Tier
Determine your pricing model: overcome governmental challenges and hear about what worked for Roche in Vietnam. ... Safeguard your reputation:employ a model of good corporate governance and learn how to overcome local corruptio n.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- Send Us a Message
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Keytruda doubles five-year survival rate in NSCLC
- Researchers call on Pfizer to delay COVID-19 vaccine application
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Covid-19 redefines rules of customer engagement
- Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
- Aurora extends exclusive collaboration with Patient Intelligence Panel (PIP Health)
- Moderna’s COVID-19 vaccine generates strong immune response in older adults
- Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms
- What makes a great launch leader and launch team?
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Covid-19 redefines rules of customer engagement
- Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
- Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
- Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
- The concordance conundrum: understanding the complexities of behaviour change
- Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
Quick links
Infographics
